Louis Denis

Title: Louis Denis - Innovator in Cancer Treatment

Introduction

Louis Denis is a notable inventor based in Wiesbaden, Germany. He has made significant contributions to the field of cancer treatment, particularly in addressing non-small cell lung cancer. His innovative approach has the potential to improve patient outcomes and advance medical science.

Latest Patents

Louis Denis holds a patent for a method directed at the treatment of cancers driven by deregulated Human Epidermal Growth Factor Receptor (HER/Human EGFR). The patent describes a method of administering an irreversible tyrosine kinase inhibitor (TKI) in a continuous regimen, along with a monoclonal antibody (mAB) administered according to a specific dosing regimen. This innovative treatment method aims to provide effective care for patients suffering from this challenging form of cancer. He has 1 patent to his name.

Career Highlights

Louis Denis is associated with Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His work at the company has focused on developing advanced treatment methods that target specific cancer pathways. His dedication to research and innovation has positioned him as a key figure in the fight against cancer.

Collaborations

Louis Denis has collaborated with esteemed colleagues, including Robert Michael Lorence and Mehdi Shahidi. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of cancer research.

Conclusion

Louis Denis is a pioneering inventor whose work in cancer treatment exemplifies the impact of innovation in medicine. His contributions are vital in the ongoing battle against cancer, and his patent reflects a commitment to improving patient care.